| Model Number |
367963 |
| Medical Device Problem Code |
Device Ingredient or Reagent Problem (2910)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
05/23/2022
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Date of event: unknown.The date received by manufacturer has been used for this field.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
|
| |
|
Event or Problem Description
|
|
It was reported when using the bd vacutainer® pst¿ gel and lithium heparinn (lh) blood collection tube there was clotting/micro clots/fibrin clots.This additive abnormality and sample quality events occurred 5 times each.The following information was provided by the initial reporter.The customer stated: "the pst tube is clotting.Potentially no heparin in the tube.".
|
| |
|
Additional Manufacturer Narrative
|
|
H6: investigation summary : bd had not received samples, but 1 photo was provided for investigation.The photo was reviewed and the indicated failure mode for fibrin was observed, however additive abnormality was not observed.Additionally, retention samples of the incident lot were selected from bd inventory for evaluation and upon completion, the indicated failure mode for fibrin and additive abnormality was not observed.No difficulties were encountered during blood collection and all tubes appeared to exhibit proper fill.Bd was unable to duplicate the customer¿s indicated failure (fibrin strand(s)/fibrin mass) because the defect was not evident in the testing of the complaint lot samples.All samples (retain and control lots) demonstrated clinically acceptable performance for all visual observations evaluated.Based on a review of the device history record for the incident lot, all product specifications and requirements for lot release were met.There were no related quality issues during manufacturing of the product.This complaint has been confirmed for the indicated failure mode fibrin based on photos only.This complaint has not been confirmed for the indicated failure mode additive abnormality.Bd was not able to identify a root cause for the indicated failure mode.H3 other text : see h10.
|
| |
|
Event or Problem Description
|
|
It was reported when using the bd vacutainer® pst¿ gel and lithium heparinn (lh) blood collection tube there was clotting/micro clots/fibrin clots.This additive abnormality and sample quality events occurred 5 times each.The following information was provided by the initial reporter.The customer stated: "the pst tube is clotting.Potentially no heparin in the tube.".
|
| |
|
Search Alerts/Recalls
|